SM

Sachin Mohanrao Ingewar

Active Director Director DIN 03119317
DIN 03119317 First appointment Dec 2023
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Dec 2023
Shareholding value β€’β€’β€’β€’ Premium profile

About Sachin Mohanrao Ingewar

Data last updated:

Sachin Mohanrao Ingewar is a Director at Feed2health Solutions Private Limited (since 2023).

DIN 03119317
Primary Designation Director
First Appointment 03 Dec 2023
Oldest Company Age 2 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director03 Dec 20232023Active

Board colleagues of Sachin Mohanrao Ingewar

Directorship timeline

Open interactive timeline →
Feed2health Solutions Private Limited
Premium access

Shareholding and investment profile for Sachin Mohanrao Ingewar

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Sachin Mohanrao Ingewar

Sachin Mohanrao Ingewar currently holds 1 directorship: Feed2health Solutions Private Limited (Director, since 03 Dec 2023).

Sachin Mohanrao Ingewar was first appointed on 03 Dec 2023 as Director at Feed2health Solutions Private Limited.

The current boards of Sachin Mohanrao Ingewar's companies include Rituparna Sujoy Mallick (Feed2health Solutions Private Limited), Rohan Suresh Mehra (Feed2health Solutions Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available